123 related articles for article (PubMed ID: 28385452)
1. A Detailed Analysis of Gene Expression in Human Basal, Luminal, and Stromal Cell Populations from Benign Prostatic Hyperplasia Tissues and Comparisons with Cultured Basal Cells.
Rane JK; Droop AP; Maitland NJ
Eur Urol; 2017 Jul; 72(1):157-159. PubMed ID: 28385452
[No Abstract] [Full Text] [Related]
2. Distinctive gene expression of prostatic stromal cells cultured from diseased versus normal tissues.
Zhao H; Ramos CF; Brooks JD; Peehl DM
J Cell Physiol; 2007 Jan; 210(1):111-21. PubMed ID: 17044071
[TBL] [Abstract][Full Text] [Related]
3. Selective estrogen receptor modulators regulate stromal proliferation in human benign prostatic hyperplasia by multiple beneficial mechanisms--action of two new agents.
Kumar R; Verma V; Sarswat A; Maikhuri JP; Jain A; Jain RK; Sharma VL; Dalela D; Gupta G
Invest New Drugs; 2012 Apr; 30(2):582-93. PubMed ID: 21181231
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-18 may lead to benign prostatic hyperplasia via thrombospondin-1 production in prostatic smooth muscle cells.
Hamakawa T; Sasaki S; Shibata Y; Imura M; Kubota Y; Kojima Y; Kohri K
Prostate; 2014 May; 74(6):590-601. PubMed ID: 24615654
[TBL] [Abstract][Full Text] [Related]
5. The exosome-like vesicles derived from androgen exposed-prostate stromal cells promote epithelial cells proliferation and epithelial-mesenchymal transition.
Chen J; Rong N; Liu M; Xu C; Xiong Q; Lei Y
Toxicol Appl Pharmacol; 2021 Jan; 411():115384. PubMed ID: 33359661
[TBL] [Abstract][Full Text] [Related]
6. Dickkopf-related protein 3 promotes pathogenic stromal remodeling in benign prostatic hyperplasia and prostate cancer.
Zenzmaier C; Sampson N; Plas E; Berger P
Prostate; 2013 Sep; 73(13):1441-52. PubMed ID: 23765731
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-8 is a paracrine inducer of fibroblast growth factor 2, a stromal and epithelial growth factor in benign prostatic hyperplasia.
Giri D; Ittmann M
Am J Pathol; 2001 Jul; 159(1):139-47. PubMed ID: 11438462
[TBL] [Abstract][Full Text] [Related]
8. Non-Cell-Autonomous Regulation of Prostate Epithelial Homeostasis by Androgen Receptor.
Zhang B; Kwon OJ; Henry G; Malewska A; Wei X; Zhang L; Brinkley W; Zhang Y; Castro PD; Titus M; Chen R; Sayeeduddin M; Raj GV; Mauck R; Roehrborn C; Creighton CJ; Strand DW; Ittmann MM; Xin L
Mol Cell; 2016 Sep; 63(6):976-89. PubMed ID: 27594448
[TBL] [Abstract][Full Text] [Related]
9. Promotion of epithelial hyperplasia by interleukin-8-CXCR axis in human prostate.
Smith DK; Hasanali SL; Wang J; Kallifatidis G; Morera DS; Jordan AR; Terris MK; Klaassen Z; Bollag R; Lokeshwar VB; Lokeshwar BL
Prostate; 2020 Sep; 80(12):938-949. PubMed ID: 32542667
[TBL] [Abstract][Full Text] [Related]
10. Analysis of gene expression in prostate cancer epithelial and interstitial stromal cells using laser capture microdissection.
Gregg JL; Brown KE; Mintz EM; Piontkivska H; Fraizer GC
BMC Cancer; 2010 Apr; 10():165. PubMed ID: 20426842
[TBL] [Abstract][Full Text] [Related]
11. Stromal response to prostate cancer: nanotechnology-based detection of thioredoxin-interacting protein partners distinguishes prostate cancer associated stroma from that of benign prostatic hyperplasia.
Singer E; Linehan J; Babilonia G; Imam SA; Smith D; Loera S; Wilson T; Smith S
PLoS One; 2013; 8(6):e60562. PubMed ID: 23762225
[TBL] [Abstract][Full Text] [Related]
12. Profiling of differential expression of messenger RNA in normal, benign, and metastatic prostate cell lines.
Chakrabarti R; Robles LD; Gibson J; Muroski M
Cancer Genet Cytogenet; 2002 Dec; 139(2):115-25. PubMed ID: 12550771
[TBL] [Abstract][Full Text] [Related]
13. Abnormal expression of Rab27B in prostatic epithelial cells of benign prostatic hyperplasia alters intercellular communication.
Dai Y; Ai B; Liu Y; Pascal LE; Wang Z; Dhir R; Sun X; Jiang Y
Int J Biochem Cell Biol; 2021 Feb; 131():105898. PubMed ID: 33285290
[TBL] [Abstract][Full Text] [Related]
14. VAT-1 is a novel pathogenic factor of progressive benign prostatic hyperplasia.
Mori F; Tanigawa K; Endo K; Minamiguchi K; Abe M; Yamada S; Miyoshi K
Prostate; 2011 Oct; 71(14):1579-86. PubMed ID: 21394740
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of CYR61, an extracellular matrix signaling protein, in human benign prostatic hyperplasia and its regulation by lysophosphatidic acid.
Sakamoto S; Yokoyama M; Zhang X; Prakash K; Nagao K; Hatanaka T; Getzenberg RH; Kakehi Y
Endocrinology; 2004 Jun; 145(6):2929-40. PubMed ID: 14988385
[TBL] [Abstract][Full Text] [Related]
16. [Stromal cells inhibit Kallikrein 7 expression in the epithelial cells of benign prostate hyperplasia].
Yang XL; Xuan Q; Huang FY; Pang YH; Mo ZN
Zhonghua Nan Ke Xue; 2011 Apr; 17(4):305-9. PubMed ID: 21548205
[TBL] [Abstract][Full Text] [Related]
17. M2a macrophage can rescue proliferation and gene expression of benign prostate hyperplasia epithelial and stroma cells from insulin-like growth factor 1 knockdown.
Qian Q; He W; Liu D; Yin J; Ye L; Chen P; Xu D; Liu J; Li Y; Zeng G; Li M; Wu Z; Zhang Y; Wang X; DiSanto ME; Zhang X
Prostate; 2021 Jun; 81(9):530-542. PubMed ID: 33861464
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation of Dkk-3 expression in benign and malignant prostatic tissue.
Zenzmaier C; Untergasser G; Hermann M; Dirnhofer S; Sampson N; Berger P
Prostate; 2008 Apr; 68(5):540-7. PubMed ID: 18247400
[TBL] [Abstract][Full Text] [Related]
19. Gray level entropy matrix is a superior predictor than multiplex ELISA in the detection of reactive stroma and metastatic potential of high-grade prostatic adenocarcinoma.
Jia X; Sun Y; Wang B
IUBMB Life; 2014 Dec; 66(12):847-53. PubMed ID: 25631296
[TBL] [Abstract][Full Text] [Related]
20. Prostatic osteopontin expression is associated with symptomatic benign prostatic hyperplasia.
Popovics P; Awadallah WN; Kohrt SE; Case TC; Miller NL; Ricke EA; Huang W; Ramirez-Solano M; Liu Q; Vezina CM; Matusik RJ; Ricke WA; Grabowska MM
Prostate; 2020 Jul; 80(10):731-741. PubMed ID: 32356572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
